News/ News/ Oncology CTI wins over FDA to claim early review of myelofibrosis drug Phil Taylor CTI BioPharma, fda, Haematology, myelofibrosis, Oncology, pacritinib, thrombocytopenia 0 Comment Shares in US biotech CTI BioPharma have shot up after the FDA agreed to an accelerated review early Share X CTI wins over FDA to claim early review of myelofibrosis drug https://pharmaphorum.com/news/cti-wins-over-fda-to-claim-early-review-of-myelofibrosis-drug/